nodes	percent_of_prediction	percent_of_DWPC	metapath
Pramipexole—HTR1D—meninx—peripheral nervous system neoplasm	0.0268	0.125	CbGeAlD
Pramipexole—HTR1B—dura mater—peripheral nervous system neoplasm	0.0255	0.119	CbGeAlD
Pramipexole—HTR1D—dura mater—peripheral nervous system neoplasm	0.0247	0.115	CbGeAlD
Pramipexole—HTR2A—phrenic nerve—peripheral nervous system neoplasm	0.0144	0.0673	CbGeAlD
Pramipexole—HTR1B—trigeminal nerve—peripheral nervous system neoplasm	0.011	0.0512	CbGeAlD
Pramipexole—HTR1D—trigeminal nerve—peripheral nervous system neoplasm	0.0106	0.0495	CbGeAlD
Pramipexole—HTR1B—cranial nerve—peripheral nervous system neoplasm	0.00781	0.0365	CbGeAlD
Pramipexole—HTR1D—cranial nerve—peripheral nervous system neoplasm	0.00756	0.0353	CbGeAlD
Pramipexole—DRD5—ganglion—peripheral nervous system neoplasm	0.00638	0.0298	CbGeAlD
Pramipexole—HTR2A—trigeminal nerve—peripheral nervous system neoplasm	0.00527	0.0246	CbGeAlD
Pramipexole—DRD1—nerve—peripheral nervous system neoplasm	0.00494	0.0231	CbGeAlD
Pramipexole—HTR2A—vagus nerve—peripheral nervous system neoplasm	0.00493	0.023	CbGeAlD
Pramipexole—DRD1—ganglion—peripheral nervous system neoplasm	0.00488	0.0228	CbGeAlD
Pramipexole—HTR1B—ganglion—peripheral nervous system neoplasm	0.00395	0.0185	CbGeAlD
Pramipexole—SLC22A1—ganglion—peripheral nervous system neoplasm	0.00386	0.018	CbGeAlD
Pramipexole—HTR1D—ganglion—peripheral nervous system neoplasm	0.00383	0.0179	CbGeAlD
Pramipexole—HTR2C—ganglion—peripheral nervous system neoplasm	0.00379	0.0177	CbGeAlD
Pramipexole—HTR2A—cranial nerve—peripheral nervous system neoplasm	0.00376	0.0175	CbGeAlD
Pramipexole—HTR2A—pons—peripheral nervous system neoplasm	0.00371	0.0173	CbGeAlD
Pramipexole—HTR1A—ganglion—peripheral nervous system neoplasm	0.00319	0.0149	CbGeAlD
Pramipexole—DRD2—nerve—peripheral nervous system neoplasm	0.00292	0.0136	CbGeAlD
Pramipexole—DRD2—ganglion—peripheral nervous system neoplasm	0.00288	0.0135	CbGeAlD
Pramipexole—SLC22A2—trigeminal ganglion—peripheral nervous system neoplasm	0.00269	0.0125	CbGeAlD
Pramipexole—DRD1—brainstem—peripheral nervous system neoplasm	0.00212	0.0099	CbGeAlD
Pramipexole—HTR1B—trigeminal ganglion—peripheral nervous system neoplasm	0.00194	0.00907	CbGeAlD
Pramipexole—HTR2A—nerve—peripheral nervous system neoplasm	0.00192	0.00899	CbGeAlD
Pramipexole—HTR2A—ganglion—peripheral nervous system neoplasm	0.0019	0.00888	CbGeAlD
Pramipexole—HTR1D—trigeminal ganglion—peripheral nervous system neoplasm	0.00188	0.00878	CbGeAlD
Pramipexole—HTR1B—brainstem—peripheral nervous system neoplasm	0.00172	0.00802	CbGeAlD
Pramipexole—HTR1D—brainstem—peripheral nervous system neoplasm	0.00166	0.00777	CbGeAlD
Pramipexole—HTR2C—brainstem—peripheral nervous system neoplasm	0.00165	0.00769	CbGeAlD
Pramipexole—HTR1A—brainstem—peripheral nervous system neoplasm	0.00139	0.00647	CbGeAlD
Pramipexole—ADRA2C—trigeminal ganglion—peripheral nervous system neoplasm	0.00138	0.00643	CbGeAlD
Pramipexole—ADRA2C—parotid gland—peripheral nervous system neoplasm	0.0013	0.00606	CbGeAlD
Pramipexole—DRD2—brainstem—peripheral nervous system neoplasm	0.00125	0.00585	CbGeAlD
Pramipexole—ADRA2A—trigeminal ganglion—peripheral nervous system neoplasm	0.0011	0.00513	CbGeAlD
Pramipexole—HTR2A—brainstem—peripheral nervous system neoplasm	0.000826	0.00386	CbGeAlD
Pramipexole—HTR1A—cerebellum—peripheral nervous system neoplasm	0.000684	0.00319	CbGeAlD
Pramipexole—DRD2—cerebellum—peripheral nervous system neoplasm	0.000618	0.00288	CbGeAlD
Pramipexole—ADRA2C—cerebellum—peripheral nervous system neoplasm	0.0006	0.0028	CbGeAlD
Pramipexole—ADRA2A—cerebellum—peripheral nervous system neoplasm	0.000479	0.00224	CbGeAlD
Pramipexole—HTR2A—cerebellum—peripheral nervous system neoplasm	0.000407	0.0019	CbGeAlD
Pramipexole—Somnolence—Etoposide—peripheral nervous system neoplasm	0.00012	0.000174	CcSEcCtD
Pramipexole—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.00012	0.000174	CcSEcCtD
Pramipexole—Asthenia—Vincristine—peripheral nervous system neoplasm	0.00012	0.000173	CcSEcCtD
Pramipexole—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.000119	0.000173	CcSEcCtD
Pramipexole—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000119	0.000172	CcSEcCtD
Pramipexole—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000119	0.000172	CcSEcCtD
Pramipexole—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000119	0.000172	CcSEcCtD
Pramipexole—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000119	0.000172	CcSEcCtD
Pramipexole—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000172	CcSEcCtD
Pramipexole—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000118	0.000172	CcSEcCtD
Pramipexole—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000118	0.000171	CcSEcCtD
Pramipexole—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000117	0.00017	CcSEcCtD
Pramipexole—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000169	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000117	0.000169	CcSEcCtD
Pramipexole—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000117	0.000169	CcSEcCtD
Pramipexole—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000116	0.000169	CcSEcCtD
Pramipexole—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000169	CcSEcCtD
Pramipexole—Constipation—Etoposide—peripheral nervous system neoplasm	0.000116	0.000167	CcSEcCtD
Pramipexole—Pain—Etoposide—peripheral nervous system neoplasm	0.000116	0.000167	CcSEcCtD
Pramipexole—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000115	0.000167	CcSEcCtD
Pramipexole—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000115	0.000167	CcSEcCtD
Pramipexole—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.000167	CcSEcCtD
Pramipexole—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.000166	CcSEcCtD
Pramipexole—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000114	0.000166	CcSEcCtD
Pramipexole—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000114	0.000165	CcSEcCtD
Pramipexole—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000114	0.000165	CcSEcCtD
Pramipexole—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.000165	CcSEcCtD
Pramipexole—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000113	0.000164	CcSEcCtD
Pramipexole—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000163	CcSEcCtD
Pramipexole—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000163	CcSEcCtD
Pramipexole—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000163	CcSEcCtD
Pramipexole—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000162	CcSEcCtD
Pramipexole—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000111	0.000162	CcSEcCtD
Pramipexole—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000111	0.000161	CcSEcCtD
Pramipexole—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000111	0.000161	CcSEcCtD
Pramipexole—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000111	0.000161	CcSEcCtD
Pramipexole—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000111	0.000161	CcSEcCtD
Pramipexole—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.000111	0.00016	CcSEcCtD
Pramipexole—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.00011	0.00016	CcSEcCtD
Pramipexole—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00011	0.00016	CcSEcCtD
Pramipexole—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00011	0.000159	CcSEcCtD
Pramipexole—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000159	CcSEcCtD
Pramipexole—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000159	CcSEcCtD
Pramipexole—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000159	CcSEcCtD
Pramipexole—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000109	0.000158	CcSEcCtD
Pramipexole—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000109	0.000158	CcSEcCtD
Pramipexole—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000109	0.000157	CcSEcCtD
Pramipexole—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000109	0.000157	CcSEcCtD
Pramipexole—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000108	0.000157	CcSEcCtD
Pramipexole—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000157	CcSEcCtD
Pramipexole—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000156	CcSEcCtD
Pramipexole—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000107	0.000156	CcSEcCtD
Pramipexole—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000107	0.000155	CcSEcCtD
Pramipexole—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000107	0.000155	CcSEcCtD
Pramipexole—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000107	0.000155	CcSEcCtD
Pramipexole—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000155	CcSEcCtD
Pramipexole—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000155	CcSEcCtD
Pramipexole—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000154	CcSEcCtD
Pramipexole—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000106	0.000154	CcSEcCtD
Pramipexole—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000106	0.000153	CcSEcCtD
Pramipexole—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000153	CcSEcCtD
Pramipexole—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000153	CcSEcCtD
Pramipexole—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000153	CcSEcCtD
Pramipexole—Rash—Vincristine—peripheral nervous system neoplasm	0.000105	0.000152	CcSEcCtD
Pramipexole—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000105	0.000152	CcSEcCtD
Pramipexole—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000152	CcSEcCtD
Pramipexole—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000152	CcSEcCtD
Pramipexole—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000152	CcSEcCtD
Pramipexole—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000151	CcSEcCtD
Pramipexole—Headache—Vincristine—peripheral nervous system neoplasm	0.000104	0.000151	CcSEcCtD
Pramipexole—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000151	CcSEcCtD
Pramipexole—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.00015	CcSEcCtD
Pramipexole—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000149	CcSEcCtD
Pramipexole—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000103	0.000149	CcSEcCtD
Pramipexole—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000149	CcSEcCtD
Pramipexole—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000101	0.000146	CcSEcCtD
Pramipexole—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.0001	0.000146	CcSEcCtD
Pramipexole—Eye disorder—Epirubicin—peripheral nervous system neoplasm	9.96e-05	0.000144	CcSEcCtD
Pramipexole—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	9.95e-05	0.000144	CcSEcCtD
Pramipexole—Tinnitus—Epirubicin—peripheral nervous system neoplasm	9.94e-05	0.000144	CcSEcCtD
Pramipexole—Nausea—Vincristine—peripheral nervous system neoplasm	9.91e-05	0.000144	CcSEcCtD
Pramipexole—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	9.89e-05	0.000143	CcSEcCtD
Pramipexole—Flushing—Epirubicin—peripheral nervous system neoplasm	9.89e-05	0.000143	CcSEcCtD
Pramipexole—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	9.89e-05	0.000143	CcSEcCtD
Pramipexole—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	9.81e-05	0.000142	CcSEcCtD
Pramipexole—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	9.79e-05	0.000142	CcSEcCtD
Pramipexole—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	9.74e-05	0.000141	CcSEcCtD
Pramipexole—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	9.72e-05	0.000141	CcSEcCtD
Pramipexole—Asthenia—Etoposide—peripheral nervous system neoplasm	9.69e-05	0.00014	CcSEcCtD
Pramipexole—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	9.69e-05	0.00014	CcSEcCtD
Pramipexole—Angiopathy—Epirubicin—peripheral nervous system neoplasm	9.67e-05	0.00014	CcSEcCtD
Pramipexole—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	9.67e-05	0.00014	CcSEcCtD
Pramipexole—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	9.63e-05	0.00014	CcSEcCtD
Pramipexole—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	9.61e-05	0.000139	CcSEcCtD
Pramipexole—Chills—Epirubicin—peripheral nervous system neoplasm	9.56e-05	0.000139	CcSEcCtD
Pramipexole—Pruritus—Etoposide—peripheral nervous system neoplasm	9.56e-05	0.000139	CcSEcCtD
Pramipexole—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	9.51e-05	0.000138	CcSEcCtD
Pramipexole—Alopecia—Epirubicin—peripheral nervous system neoplasm	9.42e-05	0.000137	CcSEcCtD
Pramipexole—Vomiting—Cisplatin—peripheral nervous system neoplasm	9.38e-05	0.000136	CcSEcCtD
Pramipexole—Mental disorder—Epirubicin—peripheral nervous system neoplasm	9.34e-05	0.000135	CcSEcCtD
Pramipexole—Rash—Cisplatin—peripheral nervous system neoplasm	9.3e-05	0.000135	CcSEcCtD
Pramipexole—Dermatitis—Cisplatin—peripheral nervous system neoplasm	9.29e-05	0.000135	CcSEcCtD
Pramipexole—Malnutrition—Epirubicin—peripheral nervous system neoplasm	9.28e-05	0.000134	CcSEcCtD
Pramipexole—Erythema—Epirubicin—peripheral nervous system neoplasm	9.28e-05	0.000134	CcSEcCtD
Pramipexole—Diarrhoea—Etoposide—peripheral nervous system neoplasm	9.24e-05	0.000134	CcSEcCtD
Pramipexole—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	9.22e-05	0.000134	CcSEcCtD
Pramipexole—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	9.2e-05	0.000133	CcSEcCtD
Pramipexole—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	9.15e-05	0.000133	CcSEcCtD
Pramipexole—Flushing—Doxorubicin—peripheral nervous system neoplasm	9.15e-05	0.000133	CcSEcCtD
Pramipexole—Flatulence—Epirubicin—peripheral nervous system neoplasm	9.14e-05	0.000133	CcSEcCtD
Pramipexole—Tension—Epirubicin—peripheral nervous system neoplasm	9.11e-05	0.000132	CcSEcCtD
Pramipexole—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	9.09e-05	0.000132	CcSEcCtD
Pramipexole—Nervousness—Epirubicin—peripheral nervous system neoplasm	9.01e-05	0.000131	CcSEcCtD
Pramipexole—Back pain—Epirubicin—peripheral nervous system neoplasm	8.98e-05	0.00013	CcSEcCtD
Pramipexole—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	8.95e-05	0.00013	CcSEcCtD
Pramipexole—Dizziness—Etoposide—peripheral nervous system neoplasm	8.93e-05	0.000129	CcSEcCtD
Pramipexole—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	8.92e-05	0.000129	CcSEcCtD
Pramipexole—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	8.91e-05	0.000129	CcSEcCtD
Pramipexole—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	8.89e-05	0.000129	CcSEcCtD
Pramipexole—Chills—Doxorubicin—peripheral nervous system neoplasm	8.85e-05	0.000128	CcSEcCtD
Pramipexole—Nausea—Cisplatin—peripheral nervous system neoplasm	8.76e-05	0.000127	CcSEcCtD
Pramipexole—Vision blurred—Epirubicin—peripheral nervous system neoplasm	8.75e-05	0.000127	CcSEcCtD
Pramipexole—Alopecia—Doxorubicin—peripheral nervous system neoplasm	8.72e-05	0.000126	CcSEcCtD
Pramipexole—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	8.64e-05	0.000125	CcSEcCtD
Pramipexole—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	8.61e-05	0.000125	CcSEcCtD
Pramipexole—Vomiting—Etoposide—peripheral nervous system neoplasm	8.59e-05	0.000124	CcSEcCtD
Pramipexole—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	8.59e-05	0.000124	CcSEcCtD
Pramipexole—Erythema—Doxorubicin—peripheral nervous system neoplasm	8.59e-05	0.000124	CcSEcCtD
Pramipexole—Anaemia—Epirubicin—peripheral nervous system neoplasm	8.58e-05	0.000124	CcSEcCtD
Pramipexole—Agitation—Epirubicin—peripheral nervous system neoplasm	8.53e-05	0.000124	CcSEcCtD
Pramipexole—Rash—Etoposide—peripheral nervous system neoplasm	8.52e-05	0.000123	CcSEcCtD
Pramipexole—Dermatitis—Etoposide—peripheral nervous system neoplasm	8.51e-05	0.000123	CcSEcCtD
Pramipexole—Headache—Etoposide—peripheral nervous system neoplasm	8.46e-05	0.000123	CcSEcCtD
Pramipexole—Flatulence—Doxorubicin—peripheral nervous system neoplasm	8.46e-05	0.000123	CcSEcCtD
Pramipexole—Tension—Doxorubicin—peripheral nervous system neoplasm	8.43e-05	0.000122	CcSEcCtD
Pramipexole—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	8.41e-05	0.000122	CcSEcCtD
Pramipexole—Malaise—Epirubicin—peripheral nervous system neoplasm	8.37e-05	0.000121	CcSEcCtD
Pramipexole—Nervousness—Doxorubicin—peripheral nervous system neoplasm	8.34e-05	0.000121	CcSEcCtD
Pramipexole—Vertigo—Epirubicin—peripheral nervous system neoplasm	8.34e-05	0.000121	CcSEcCtD
Pramipexole—Syncope—Epirubicin—peripheral nervous system neoplasm	8.32e-05	0.000121	CcSEcCtD
Pramipexole—Leukopenia—Epirubicin—peripheral nervous system neoplasm	8.31e-05	0.00012	CcSEcCtD
Pramipexole—Back pain—Doxorubicin—peripheral nervous system neoplasm	8.31e-05	0.00012	CcSEcCtD
Pramipexole—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	8.25e-05	0.00012	CcSEcCtD
Pramipexole—Palpitations—Epirubicin—peripheral nervous system neoplasm	8.2e-05	0.000119	CcSEcCtD
Pramipexole—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	8.16e-05	0.000118	CcSEcCtD
Pramipexole—Cough—Epirubicin—peripheral nervous system neoplasm	8.1e-05	0.000117	CcSEcCtD
Pramipexole—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	8.09e-05	0.000117	CcSEcCtD
Pramipexole—Convulsion—Epirubicin—peripheral nervous system neoplasm	8.04e-05	0.000117	CcSEcCtD
Pramipexole—Nausea—Etoposide—peripheral nervous system neoplasm	8.03e-05	0.000116	CcSEcCtD
Pramipexole—Hypertension—Epirubicin—peripheral nervous system neoplasm	8.01e-05	0.000116	CcSEcCtD
Pramipexole—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	7.97e-05	0.000115	CcSEcCtD
Pramipexole—Anaemia—Doxorubicin—peripheral nervous system neoplasm	7.94e-05	0.000115	CcSEcCtD
Pramipexole—Chest pain—Epirubicin—peripheral nervous system neoplasm	7.9e-05	0.000114	CcSEcCtD
Pramipexole—Myalgia—Epirubicin—peripheral nervous system neoplasm	7.9e-05	0.000114	CcSEcCtD
Pramipexole—Arthralgia—Epirubicin—peripheral nervous system neoplasm	7.9e-05	0.000114	CcSEcCtD
Pramipexole—Agitation—Doxorubicin—peripheral nervous system neoplasm	7.89e-05	0.000114	CcSEcCtD
Pramipexole—Anxiety—Epirubicin—peripheral nervous system neoplasm	7.87e-05	0.000114	CcSEcCtD
Pramipexole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	7.85e-05	0.000114	CcSEcCtD
Pramipexole—Discomfort—Epirubicin—peripheral nervous system neoplasm	7.81e-05	0.000113	CcSEcCtD
Pramipexole—Malaise—Doxorubicin—peripheral nervous system neoplasm	7.74e-05	0.000112	CcSEcCtD
Pramipexole—Dry mouth—Epirubicin—peripheral nervous system neoplasm	7.73e-05	0.000112	CcSEcCtD
Pramipexole—Vertigo—Doxorubicin—peripheral nervous system neoplasm	7.71e-05	0.000112	CcSEcCtD
Pramipexole—Syncope—Doxorubicin—peripheral nervous system neoplasm	7.7e-05	0.000112	CcSEcCtD
Pramipexole—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	7.69e-05	0.000111	CcSEcCtD
Pramipexole—Confusional state—Epirubicin—peripheral nervous system neoplasm	7.64e-05	0.000111	CcSEcCtD
Pramipexole—Palpitations—Doxorubicin—peripheral nervous system neoplasm	7.59e-05	0.00011	CcSEcCtD
Pramipexole—Oedema—Epirubicin—peripheral nervous system neoplasm	7.57e-05	0.00011	CcSEcCtD
Pramipexole—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	7.55e-05	0.000109	CcSEcCtD
Pramipexole—Infection—Epirubicin—peripheral nervous system neoplasm	7.52e-05	0.000109	CcSEcCtD
Pramipexole—Cough—Doxorubicin—peripheral nervous system neoplasm	7.49e-05	0.000109	CcSEcCtD
Pramipexole—Shock—Epirubicin—peripheral nervous system neoplasm	7.45e-05	0.000108	CcSEcCtD
Pramipexole—Convulsion—Doxorubicin—peripheral nervous system neoplasm	7.44e-05	0.000108	CcSEcCtD
Pramipexole—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	7.43e-05	0.000108	CcSEcCtD
Pramipexole—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	7.42e-05	0.000107	CcSEcCtD
Pramipexole—Hypertension—Doxorubicin—peripheral nervous system neoplasm	7.41e-05	0.000107	CcSEcCtD
Pramipexole—Tachycardia—Epirubicin—peripheral nervous system neoplasm	7.39e-05	0.000107	CcSEcCtD
Pramipexole—Skin disorder—Epirubicin—peripheral nervous system neoplasm	7.36e-05	0.000107	CcSEcCtD
Pramipexole—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	7.32e-05	0.000106	CcSEcCtD
Pramipexole—Myalgia—Doxorubicin—peripheral nervous system neoplasm	7.31e-05	0.000106	CcSEcCtD
Pramipexole—Chest pain—Doxorubicin—peripheral nervous system neoplasm	7.31e-05	0.000106	CcSEcCtD
Pramipexole—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	7.31e-05	0.000106	CcSEcCtD
Pramipexole—Anxiety—Doxorubicin—peripheral nervous system neoplasm	7.28e-05	0.000106	CcSEcCtD
Pramipexole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	7.26e-05	0.000105	CcSEcCtD
Pramipexole—Discomfort—Doxorubicin—peripheral nervous system neoplasm	7.22e-05	0.000105	CcSEcCtD
Pramipexole—Anorexia—Epirubicin—peripheral nervous system neoplasm	7.22e-05	0.000105	CcSEcCtD
Pramipexole—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	7.15e-05	0.000104	CcSEcCtD
Pramipexole—Hypotension—Epirubicin—peripheral nervous system neoplasm	7.08e-05	0.000103	CcSEcCtD
Pramipexole—Confusional state—Doxorubicin—peripheral nervous system neoplasm	7.07e-05	0.000102	CcSEcCtD
Pramipexole—Oedema—Doxorubicin—peripheral nervous system neoplasm	7.01e-05	0.000102	CcSEcCtD
Pramipexole—Infection—Doxorubicin—peripheral nervous system neoplasm	6.96e-05	0.000101	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	6.9e-05	0.0001	CcSEcCtD
Pramipexole—Shock—Doxorubicin—peripheral nervous system neoplasm	6.89e-05	9.99e-05	CcSEcCtD
Pramipexole—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	6.87e-05	9.96e-05	CcSEcCtD
Pramipexole—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	6.86e-05	9.94e-05	CcSEcCtD
Pramipexole—Insomnia—Epirubicin—peripheral nervous system neoplasm	6.85e-05	9.93e-05	CcSEcCtD
Pramipexole—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	6.84e-05	9.91e-05	CcSEcCtD
Pramipexole—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	6.81e-05	9.86e-05	CcSEcCtD
Pramipexole—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	6.8e-05	9.86e-05	CcSEcCtD
Pramipexole—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	6.77e-05	9.82e-05	CcSEcCtD
Pramipexole—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	6.75e-05	9.79e-05	CcSEcCtD
Pramipexole—Somnolence—Epirubicin—peripheral nervous system neoplasm	6.73e-05	9.76e-05	CcSEcCtD
Pramipexole—Anorexia—Doxorubicin—peripheral nervous system neoplasm	6.68e-05	9.68e-05	CcSEcCtD
Pramipexole—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	6.67e-05	9.66e-05	CcSEcCtD
Pramipexole—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	6.58e-05	9.54e-05	CcSEcCtD
Pramipexole—Hypotension—Doxorubicin—peripheral nervous system neoplasm	6.55e-05	9.49e-05	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	6.54e-05	9.48e-05	CcSEcCtD
Pramipexole—Fatigue—Epirubicin—peripheral nervous system neoplasm	6.53e-05	9.46e-05	CcSEcCtD
Pramipexole—Constipation—Epirubicin—peripheral nervous system neoplasm	6.48e-05	9.39e-05	CcSEcCtD
Pramipexole—Pain—Epirubicin—peripheral nervous system neoplasm	6.48e-05	9.39e-05	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	6.38e-05	9.25e-05	CcSEcCtD
Pramipexole—Insomnia—Doxorubicin—peripheral nervous system neoplasm	6.34e-05	9.19e-05	CcSEcCtD
Pramipexole—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	6.29e-05	9.12e-05	CcSEcCtD
Pramipexole—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	6.25e-05	9.05e-05	CcSEcCtD
Pramipexole—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	6.24e-05	9.04e-05	CcSEcCtD
Pramipexole—Somnolence—Doxorubicin—peripheral nervous system neoplasm	6.23e-05	9.03e-05	CcSEcCtD
Pramipexole—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	6.19e-05	8.97e-05	CcSEcCtD
Pramipexole—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	6.17e-05	8.94e-05	CcSEcCtD
Pramipexole—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	6.09e-05	8.83e-05	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	6.05e-05	8.77e-05	CcSEcCtD
Pramipexole—Fatigue—Doxorubicin—peripheral nervous system neoplasm	6.04e-05	8.76e-05	CcSEcCtD
Pramipexole—Urticaria—Epirubicin—peripheral nervous system neoplasm	6.02e-05	8.72e-05	CcSEcCtD
Pramipexole—Constipation—Doxorubicin—peripheral nervous system neoplasm	5.99e-05	8.68e-05	CcSEcCtD
Pramipexole—Pain—Doxorubicin—peripheral nervous system neoplasm	5.99e-05	8.68e-05	CcSEcCtD
Pramipexole—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	5.99e-05	8.68e-05	CcSEcCtD
Pramipexole—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	5.99e-05	8.68e-05	CcSEcCtD
Pramipexole—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	5.77e-05	8.37e-05	CcSEcCtD
Pramipexole—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	5.73e-05	8.3e-05	CcSEcCtD
Pramipexole—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	5.58e-05	8.09e-05	CcSEcCtD
Pramipexole—Urticaria—Doxorubicin—peripheral nervous system neoplasm	5.57e-05	8.07e-05	CcSEcCtD
Pramipexole—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	5.54e-05	8.03e-05	CcSEcCtD
Pramipexole—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	5.54e-05	8.03e-05	CcSEcCtD
Pramipexole—Asthenia—Epirubicin—peripheral nervous system neoplasm	5.43e-05	7.87e-05	CcSEcCtD
Pramipexole—Pruritus—Epirubicin—peripheral nervous system neoplasm	5.36e-05	7.77e-05	CcSEcCtD
Pramipexole—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	5.18e-05	7.51e-05	CcSEcCtD
Pramipexole—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	5.16e-05	7.48e-05	CcSEcCtD
Pramipexole—Asthenia—Doxorubicin—peripheral nervous system neoplasm	5.03e-05	7.29e-05	CcSEcCtD
Pramipexole—Dizziness—Epirubicin—peripheral nervous system neoplasm	5.01e-05	7.26e-05	CcSEcCtD
Pramipexole—Pruritus—Doxorubicin—peripheral nervous system neoplasm	4.96e-05	7.18e-05	CcSEcCtD
Pramipexole—Vomiting—Epirubicin—peripheral nervous system neoplasm	4.82e-05	6.98e-05	CcSEcCtD
Pramipexole—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	4.79e-05	6.95e-05	CcSEcCtD
Pramipexole—Rash—Epirubicin—peripheral nervous system neoplasm	4.78e-05	6.92e-05	CcSEcCtD
Pramipexole—Dermatitis—Epirubicin—peripheral nervous system neoplasm	4.77e-05	6.91e-05	CcSEcCtD
Pramipexole—Headache—Epirubicin—peripheral nervous system neoplasm	4.74e-05	6.88e-05	CcSEcCtD
Pramipexole—Dizziness—Doxorubicin—peripheral nervous system neoplasm	4.63e-05	6.72e-05	CcSEcCtD
Pramipexole—Nausea—Epirubicin—peripheral nervous system neoplasm	4.5e-05	6.52e-05	CcSEcCtD
Pramipexole—Vomiting—Doxorubicin—peripheral nervous system neoplasm	4.46e-05	6.46e-05	CcSEcCtD
Pramipexole—Rash—Doxorubicin—peripheral nervous system neoplasm	4.42e-05	6.4e-05	CcSEcCtD
Pramipexole—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	4.41e-05	6.4e-05	CcSEcCtD
Pramipexole—Headache—Doxorubicin—peripheral nervous system neoplasm	4.39e-05	6.36e-05	CcSEcCtD
Pramipexole—Nausea—Doxorubicin—peripheral nervous system neoplasm	4.16e-05	6.03e-05	CcSEcCtD
Pramipexole—DRD4—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	3.83e-05	0.0004	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	3.81e-05	0.000398	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	3.77e-05	0.000394	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.75e-05	0.000392	CbGpPWpGaD
Pramipexole—DRD1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	3.73e-05	0.000389	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—TH—peripheral nervous system neoplasm	3.7e-05	0.000386	CbGpPWpGaD
Pramipexole—DRD3—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	3.68e-05	0.000384	CbGpPWpGaD
Pramipexole—SLC22A1—Neuronal System—HRAS—peripheral nervous system neoplasm	3.67e-05	0.000383	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	3.66e-05	0.000382	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—GNAS—peripheral nervous system neoplasm	3.65e-05	0.000381	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	3.64e-05	0.00038	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	3.62e-05	0.000378	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	3.62e-05	0.000378	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	3.62e-05	0.000378	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—GNAS—peripheral nervous system neoplasm	3.58e-05	0.000373	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—KNG1—peripheral nervous system neoplasm	3.57e-05	0.000373	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	3.52e-05	0.000368	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—GNAS—peripheral nervous system neoplasm	3.52e-05	0.000367	CbGpPWpGaD
Pramipexole—ADRA2B—Hemostasis—NRAS—peripheral nervous system neoplasm	3.48e-05	0.000363	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	3.45e-05	0.00036	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	3.41e-05	0.000355	CbGpPWpGaD
Pramipexole—DRD5—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	3.37e-05	0.000352	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—GNAS—peripheral nervous system neoplasm	3.36e-05	0.00035	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—BCHE—peripheral nervous system neoplasm	3.34e-05	0.000348	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	3.32e-05	0.000346	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	3.31e-05	0.000346	CbGpPWpGaD
Pramipexole—ADRA2A—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	3.31e-05	0.000345	CbGpPWpGaD
Pramipexole—ADRA2C—Hemostasis—NRAS—peripheral nervous system neoplasm	3.25e-05	0.000339	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—GNAS—peripheral nervous system neoplasm	3.24e-05	0.000338	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—KNG1—peripheral nervous system neoplasm	3.23e-05	0.000337	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	3.2e-05	0.000334	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	3.2e-05	0.000334	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	3.19e-05	0.000333	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.18e-05	0.000332	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—ABCB1—peripheral nervous system neoplasm	3.18e-05	0.000332	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	3.17e-05	0.00033	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—GNAS—peripheral nervous system neoplasm	3.15e-05	0.000329	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	3.15e-05	0.000328	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—TH—peripheral nervous system neoplasm	3.14e-05	0.000327	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—GNAS—peripheral nervous system neoplasm	3.12e-05	0.000326	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	3.11e-05	0.000325	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	3.1e-05	0.000323	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—KNG1—peripheral nervous system neoplasm	3.1e-05	0.000323	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—ABCB1—peripheral nervous system neoplasm	3.09e-05	0.000323	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	3.07e-05	0.000321	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—GNAS—peripheral nervous system neoplasm	3.02e-05	0.000315	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—KNG1—peripheral nervous system neoplasm	3.01e-05	0.000314	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.97e-05	0.00031	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—ABCB1—peripheral nervous system neoplasm	2.96e-05	0.000309	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.95e-05	0.000308	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.87e-05	0.0003	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	2.86e-05	0.000299	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.82e-05	0.000294	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	2.81e-05	0.000294	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	2.77e-05	0.000289	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.73e-05	0.000285	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.72e-05	0.000284	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.71e-05	0.000283	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.69e-05	0.000281	CbGpPWpGaD
Pramipexole—ADRA2B—Hemostasis—TP53—peripheral nervous system neoplasm	2.66e-05	0.000278	CbGpPWpGaD
Pramipexole—ADRA2A—Hemostasis—NRAS—peripheral nervous system neoplasm	2.64e-05	0.000275	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.64e-05	0.000275	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.62e-05	0.000273	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.61e-05	0.000272	CbGpPWpGaD
Pramipexole—HTR1D—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.58e-05	0.000269	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.56e-05	0.000268	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—GNAS—peripheral nervous system neoplasm	2.56e-05	0.000267	CbGpPWpGaD
Pramipexole—ADRA2B—Hemostasis—HRAS—peripheral nervous system neoplasm	2.54e-05	0.000265	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.54e-05	0.000265	CbGpPWpGaD
Pramipexole—HTR1B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.53e-05	0.000264	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	2.52e-05	0.000263	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—ABCB1—peripheral nervous system neoplasm	2.51e-05	0.000262	CbGpPWpGaD
Pramipexole—DRD4—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.49e-05	0.00026	CbGpPWpGaD
Pramipexole—ADRA2C—Hemostasis—TP53—peripheral nervous system neoplasm	2.48e-05	0.000259	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.48e-05	0.000259	CbGpPWpGaD
Pramipexole—DRD5—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.47e-05	0.000257	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.45e-05	0.000255	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.44e-05	0.000255	CbGpPWpGaD
Pramipexole—DRD5—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.4e-05	0.00025	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.39e-05	0.000249	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.38e-05	0.000248	CbGpPWpGaD
Pramipexole—ADRA2C—Hemostasis—HRAS—peripheral nervous system neoplasm	2.38e-05	0.000248	CbGpPWpGaD
Pramipexole—HTR2B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.38e-05	0.000248	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.35e-05	0.000245	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.33e-05	0.000244	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.33e-05	0.000243	CbGpPWpGaD
Pramipexole—ADRA2B—Hemostasis—AKT1—peripheral nervous system neoplasm	2.25e-05	0.000234	CbGpPWpGaD
Pramipexole—DRD1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.24e-05	0.000234	CbGpPWpGaD
Pramipexole—DRD3—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.21e-05	0.000231	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.2e-05	0.00023	CbGpPWpGaD
Pramipexole—DRD5—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.18e-05	0.000227	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.17e-05	0.000227	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.14e-05	0.000223	CbGpPWpGaD
Pramipexole—ADRA2C—Hemostasis—AKT1—peripheral nervous system neoplasm	2.1e-05	0.000219	CbGpPWpGaD
Pramipexole—ADRA2A—Hemostasis—TP53—peripheral nervous system neoplasm	2.02e-05	0.000211	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.01e-05	0.000209	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2e-05	0.000208	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.99e-05	0.000208	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.96e-05	0.000205	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.96e-05	0.000205	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.93e-05	0.000202	CbGpPWpGaD
Pramipexole—ADRA2A—Hemostasis—HRAS—peripheral nervous system neoplasm	1.93e-05	0.000201	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.93e-05	0.000201	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.92e-05	0.0002	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.89e-05	0.000197	CbGpPWpGaD
Pramipexole—HTR1D—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.89e-05	0.000197	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.88e-05	0.000196	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.86e-05	0.000194	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.86e-05	0.000194	CbGpPWpGaD
Pramipexole—HTR1B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.85e-05	0.000193	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.84e-05	0.000192	CbGpPWpGaD
Pramipexole—HTR1D—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.84e-05	0.000192	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.83e-05	0.000191	CbGpPWpGaD
Pramipexole—DRD4—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.82e-05	0.00019	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.82e-05	0.00019	CbGpPWpGaD
Pramipexole—HTR1B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.8e-05	0.000188	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.78e-05	0.000186	CbGpPWpGaD
Pramipexole—DRD4—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.77e-05	0.000185	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.75e-05	0.000183	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.74e-05	0.000181	CbGpPWpGaD
Pramipexole—HTR2B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.74e-05	0.000181	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.72e-05	0.000179	CbGpPWpGaD
Pramipexole—ADRA2A—Hemostasis—AKT1—peripheral nervous system neoplasm	1.7e-05	0.000178	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.69e-05	0.000176	CbGpPWpGaD
Pramipexole—HTR2B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.69e-05	0.000176	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.67e-05	0.000175	CbGpPWpGaD
Pramipexole—HTR1D—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.67e-05	0.000174	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.66e-05	0.000174	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.66e-05	0.000173	CbGpPWpGaD
Pramipexole—DRD1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.64e-05	0.000171	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.64e-05	0.000171	CbGpPWpGaD
Pramipexole—HTR1B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.63e-05	0.00017	CbGpPWpGaD
Pramipexole—DRD3—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.62e-05	0.000169	CbGpPWpGaD
Pramipexole—DRD4—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.61e-05	0.000168	CbGpPWpGaD
Pramipexole—DRD1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.59e-05	0.000166	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.58e-05	0.000165	CbGpPWpGaD
Pramipexole—DRD3—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.57e-05	0.000164	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.56e-05	0.000163	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.55e-05	0.000162	CbGpPWpGaD
Pramipexole—HTR2B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.53e-05	0.00016	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.53e-05	0.000159	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.52e-05	0.000159	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.51e-05	0.000158	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.5e-05	0.000156	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.49e-05	0.000156	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.49e-05	0.000155	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.49e-05	0.000155	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.47e-05	0.000153	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.46e-05	0.000152	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.46e-05	0.000152	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.45e-05	0.000151	CbGpPWpGaD
Pramipexole—DRD1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.45e-05	0.000151	CbGpPWpGaD
Pramipexole—DRD3—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.43e-05	0.000149	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.42e-05	0.000148	CbGpPWpGaD
Pramipexole—ADRA2B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.42e-05	0.000148	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.41e-05	0.000147	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.41e-05	0.000147	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.4e-05	0.000146	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.4e-05	0.000146	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.39e-05	0.000145	CbGpPWpGaD
Pramipexole—HTR1A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.37e-05	0.000143	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.37e-05	0.000143	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.36e-05	0.000142	CbGpPWpGaD
Pramipexole—HTR2C—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.36e-05	0.000142	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.36e-05	0.000142	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.35e-05	0.000141	CbGpPWpGaD
Pramipexole—ADRA2C—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.33e-05	0.000138	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.32e-05	0.000138	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.31e-05	0.000137	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.31e-05	0.000137	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.31e-05	0.000136	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.31e-05	0.000136	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.29e-05	0.000135	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.29e-05	0.000135	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.29e-05	0.000134	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.24e-05	0.00013	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.24e-05	0.000129	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.24e-05	0.000129	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.23e-05	0.000129	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.22e-05	0.000127	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.22e-05	0.000127	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.2e-05	0.000126	CbGpPWpGaD
Pramipexole—DRD2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.2e-05	0.000126	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.19e-05	0.000124	CbGpPWpGaD
Pramipexole—HTR2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.18e-05	0.000124	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.18e-05	0.000123	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.18e-05	0.000123	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.17e-05	0.000122	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.17e-05	0.000122	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.14e-05	0.000119	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.14e-05	0.000119	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.13e-05	0.000118	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.12e-05	0.000117	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.12e-05	0.000116	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.11e-05	0.000116	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.1e-05	0.000115	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.1e-05	0.000115	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.09e-05	0.000114	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.09e-05	0.000114	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.08e-05	0.000112	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.08e-05	0.000112	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.08e-05	0.000112	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.07e-05	0.000112	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.07e-05	0.000111	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.06e-05	0.000111	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.05e-05	0.00011	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.03e-05	0.000107	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.03e-05	0.000107	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.01e-05	0.000106	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	9.99e-06	0.000104	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—TP53—peripheral nervous system neoplasm	9.99e-06	0.000104	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—AKT1—peripheral nervous system neoplasm	9.86e-06	0.000103	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	9.83e-06	0.000103	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	9.78e-06	0.000102	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	9.68e-06	0.000101	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	9.65e-06	0.000101	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—HRAS—peripheral nervous system neoplasm	9.55e-06	9.97e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—AKT1—peripheral nervous system neoplasm	9.5e-06	9.91e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—MYC—peripheral nervous system neoplasm	9.31e-06	9.71e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	9.16e-06	9.56e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	9.06e-06	9.46e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—TP53—peripheral nervous system neoplasm	9.02e-06	9.41e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	8.94e-06	9.33e-05	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—AKT1—peripheral nervous system neoplasm	8.75e-06	9.13e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—TP53—peripheral nervous system neoplasm	8.71e-06	9.08e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—TP53—peripheral nervous system neoplasm	8.66e-06	9.04e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	8.62e-06	9e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	8.55e-06	8.92e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—AKT1—peripheral nervous system neoplasm	8.51e-06	8.88e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—AKT1—peripheral nervous system neoplasm	8.43e-06	8.8e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—TP53—peripheral nervous system neoplasm	8.42e-06	8.79e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	8.33e-06	8.69e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	8.33e-06	8.69e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—HRAS—peripheral nervous system neoplasm	8.28e-06	8.64e-05	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—AKT1—peripheral nervous system neoplasm	8.15e-06	8.51e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—HRAS—peripheral nervous system neoplasm	8.06e-06	8.41e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—TP53—peripheral nervous system neoplasm	7.64e-06	7.98e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	7.62e-06	7.95e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	7.52e-06	7.85e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	7.35e-06	7.67e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—AKT1—peripheral nervous system neoplasm	7.31e-06	7.63e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	7.31e-06	7.63e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	7.19e-06	7.5e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—AKT1—peripheral nervous system neoplasm	7.11e-06	7.42e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—AKT1—peripheral nervous system neoplasm	6.91e-06	7.21e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	6.84e-06	7.14e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	6.54e-06	6.83e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.45e-06	6.73e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.35e-06	6.63e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.78e-06	6.03e-05	CbGpPWpGaD
